Skewing the balance of regulatory T-cells and T-helper 17 cells in breast cancer patients

27Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study investigated the distribution of interleukin (IL)-17-producing CD4+ T-cells (T-helper [Th17] cells) in relation to CD4+CD25+CD127- cells (regulatory T-cells [Treg]) in tumour-infiltrating lymphocytes (TILs) and peripheral blood mononuclear cells (PBMCs) from breast cancer patients. The Th17 and Treg cells were evaluated by flow cytometry and reported as a percentage of total CD4+ cells. In TILs from early breast cancer patients (n = 12), the frequency of Th17 cells was significantly higher than in PBMCs (14.5 ± 7.2% versus 6.9 ± 2.1%). In TILs from patients with advanced breast cancer (n = 15), the frequency of Th17 cells was also significantly higher than that in PBMCs (9.1 ± 5.7% versus 3.2 ± 2.3%) but lower compared with early disease. The Th17/Treg ratio in TILs was markedly increased in early versus advanced disease. In conclusion, Th17 and Treg cell accumulation in the tumour microenvironment of breast cancer occurred in early disease; Th17 cell infiltration gradually decreased and Treg cells accumulated with disease progression. © 2011 Field House Publishing LLP.

Cite

CITATION STYLE

APA

Wang, J., Cai, D., Ma, B., Wu, G., & Wu, J. (2011). Skewing the balance of regulatory T-cells and T-helper 17 cells in breast cancer patients. Journal of International Medical Research, 39(3), 691–701. https://doi.org/10.1177/147323001103900301

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free